Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

TG Therapeutics Inc (NASDAQ:TGTX)

11.95
Delayed Data
As of Sep 22
 +0.15 / +1.27%
Today’s Change
4.10
Today|||52-Week Range
15.35
+156.99%
Year-to-Date
No recent news for TG Therapeutics Inc.

Today’s Trading

Previous close11.80
Today’s open11.85
Day’s range11.65 - 12.00
Volume768,812
Average volume (3 months)1,420,345
Market cap$822.6M
Dividend yield--
Data as of 4:00pm ET, 09/22/2017

Growth & Valuation

Earnings growth (last year)-15.94%
Earnings growth (this year)-11.87%
Earnings growth (next 5 years)--
Revenue growth (last year)0.00%
P/E ratioNM
Price/Sales1,496.53
Price/Book18.92

Competitors

 Today’s
change
Today’s
% change
BYSIBeyondspring Inc-0.82-2.09%
PTCTPTC Therapeutics Inc-1.53-7.63%
KERXKeryx Biopharmaceuti...+0.03+0.43%
HRTXHeron Therapeutics I...+0.05+0.33%
Data as of 4:14pm ET, 09/22/2017

Financials

Next reporting dateNovember 6, 2017
EPS forecast (this quarter)-$0.42
Annual revenue (last year)$152.4K
Annual profit (last year)-$78.3M
Net profit margin-51,353.45%

Profile

Sector
Health Technology
Industry
Biotechnology
Executive Chairman, President &
CEO
Michael Sean Weiss
Chief Financial Officer, Secretary &
Treasurer
Sean A. Power
Corporate headquarters
New York, New York

Forecasts